Tokyo, Japan

Kenichi Kamijyo

This inventor holds 2 USPTO granted patents. Top assignee: Nec Corporation. Active years: 2001-2009.


% Patents Active = 50.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kenichi Kamijyo: Innovator in Proteome Analysis

Introduction

Kenichi Kamijyo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of proteome analysis, holding a total of 2 patents. His innovative work has advanced the understanding and application of proteomics in various scientific domains.

Latest Patents

Kamijyo's latest patents include a "Proteome Analysis Method" and a "Proteome Analysis System." The proteome analysis method utilizes a tandem type mass spectrometer to calculate bond dissociation energy through molecular simulation. This method allows for the prediction of cleavage patterns of peptides, peak positions in mass spectra, and intensity ratios, ultimately aiding in protein identification. The living body internal active source estimation apparatus is designed to provide fast dipole size estimation with minimal noise interference, employing a regional dipole model and an artificial neural network for enhanced accuracy.

Career Highlights

Kenichi Kamijyo is associated with NEC Corporation, where he continues to push the boundaries of innovation in proteomics. His work has garnered attention for its practical applications in biological research and diagnostics.

Collaborations

Kamijyo has collaborated with notable colleagues, including Toshimasa Yamazaki and Minoru Asogawa, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kenichi Kamijyo's contributions to proteome analysis exemplify the impact of innovative thinking in scientific research. His patents reflect a commitment to advancing technology in the field, making him a noteworthy figure in the world of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…